{
    "code": "01055295",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01055295",
    "time": "2019-09-13 03:02:32",
    "許可證字號": "衛署藥製字第055295號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/09\/20",
    "發證日期": "99\/09\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105529501",
    "中文品名": "安骨本濃縮注射液 4 毫克\/ 5 毫升",
    "英文品名": "Bonecare Concentrate for solution for infusion 4mg\/5ml",
    "適應症": "-與標準癌症治療併用，適用於多發性骨髓瘤及固體腫瘤併有骨骼轉移之病人。用於攝護腺癌病人之骨骼轉移時，應至少接受過一種荷爾蒙治療而仍持續惡化者。-治療惡性腫瘤之高血鈣併發症(HCM)。",
    "劑型": "279注射液",
    "包裝": "5毫升塑膠小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "主成分略述": "ZOLEDRONIC ACID MONOHYDRATE",
    "主製造廠": {
        "申請商名稱": "0903620200  南光化學製藥股份有限公司",
        "申請商地址": "台南市新化區全興里中山路１００１號",
        "主製造廠": "",
        "製造廠名稱": "0903620300  南光化學製藥股份有限公司"
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6400001630",
            "成分名稱": "ZOLEDRONIC ACID MONOHYDRATE",
            "含量描述": "(eq. to Zoledronic acid 0.8mg)",
            "含量": "0.8528000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "522055295_仿單_012714-00-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055295&Seq=003&Type=9"
        },
        {
            "title": "522055295_彩盒_082814-00-104-09-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055295&Seq=003&Type=8"
        }
    ]
}